Lena Esmail Urges Action to Close Local Healthcare Gaps

September 23, 2025 10:45 AM

Lena Esmail, a nurse practitioner and CEO of QuickMed, is using her recent spotlight feature to advocate for a smarter, more local approach to healthcare. In the newly published interview titled "Lena Esmail: The Nurse Who Reimagined Local Healthcare," Esmail opens up about her roots in the Mahoning Valley-and why she believes the path to fixing healthcare starts at the community level."If you can't make a change where you start, you can't make...

Read more

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts

September 23, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday, September 25, 2025 at the Emerging Growth Conference and virtually on Tuesday, September 30, 2025 at the Lytham Partners Fall 2025 Conference.Participation Instructions for Jaguar's Virtual Presentation at the Emerging Growth ConferenceWhen: Thursday, September 25, 2025 from 2:55 - 3:05 PM Eastern...

Read more

ZetrOZ Systems' sam Wearable Ultrasound Device Helps Osteoarthritis Patient Get Back to Living

September 23, 2025 9:00 AM

Bilateral knee osteoarthritis was keeping Drew Sumrell from doing the things he wanted to do. Conventional treatments were not solving the problem. He found relief and a solution by including the sam® wearable ultrasound unit from ZetrOZ Systems as part of his treatment routine.The sam® device has proven to be an effective treatment for knee osteoarthritis and many soft-tissue injuries, as documented in multiple clinical studies, providing...

Read more

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

September 23, 2025 8:30 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, announced that members of its business development and technical teams will be in attendance at upcoming industry conferences and present posters that underscore the Company's flexible nucleic acid production solutions designed to meet...

Read more

Medical Care Technologies Inc. Introduces AI Facial Health Risk Estimator for Cardiovascular Disease Detection

September 23, 2025 8:00 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the launch of its AI Facial Health Risk Estimator, a groundbreaking technology that leverages advanced facial imaging to provide early risk detection for cardiovascular disease, one of the leading causes of death worldwide.The system uses deep neural networks trained on biometric signatures such as micro-wrinkle density, skin elasticity, and tone variations to generate a real-time...

Read more

Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans

September 23, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE® (COVID-19 Vaccine, mRNA),which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. The data from an ongoing Phase 4 clinical trial evaluating the safety, tolerability and immunogenicity of the 2025-2026 formula of mNEXSPIKE showed, on average, greater than a 16-fold increase in neutralizing antibodies...

Read more

Albany Gains New Mental Health Resource as Rivia Mind Opens New Office

September 23, 2025 7:00 AM

Rivia Mind, a mental health practice providing compassionate, evidence-based care, today announced the opening of in-person services in Albany, New York. Beginning October 1, the organization will welcome local patients for face-to-face appointments at its new location, which will provide medication management alongside Rivia Mind's virtual therapy and psychiatric offerings.The move reflects Rivia Mind's broader commitment to improving access...

Read more

CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities

September 23, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), through its wholly owned subsidiary, CBD Vault, is proud to announce that it has entered into a Letter of Intent (LOI) with a licensed dispensary in New Jersey. This powerful agreement represents not just product placement, but a transformational partnership that creates two-way retail visibility, accelerates brand recognition, and opens the door to significant new revenue streams in one of the fastest-growing...

Read more

Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay

September 23, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced the expansion of its TRUFORMA diagnostic platform with the addition of feline testing capability to its cobalamin & folate assay.Originally launched in early 2024 for canine use, this multiplexed assay-combining two critical tests in...

Read more

Viromed Medical AG initiates approval process for PulmoPlas(R) with the Federal Institute for Drugs and Medical Devices (BfArM)

September 23, 2025 5:25 AM

Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, has initiated the official approval process for its new product PulmoPlas® with the Federal Institute for Drugs and Medical Devices („Bundesinstitut für Arzneimittel und Medizinprodukte"; BfArM). With this step, the company is setting the course for the future widespread use of this novel therapy.PulmoPlas® is an innovative...

Read more

Hemogenyx Pharmaceuticals PLC Signs Letter of Intent

September 23, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has signed a Letter of Intent ("LOI") with Cellin Technologies OÜ ("Cellin"), a leading Estonian cell therapy company, to explore the commercialization of the Company's HG-CT-1 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia ("R/R AML") through the hospital exemption pathway under Estonia's Medicinal Products Act. This collaboration...

Read more

Most RPM & CCM Programs Create More Headaches Than Health

September 22, 2025 7:47 PM

Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) are the new frontier of Medicare-supported care - but the market is already crowded with half-baked solutions. For providers, the promise of better outcomes and reimbursement too often turns into a tangle of frustrated patients, overwhelmed staff, and mounting liabilities. Consider what most clinics face today:The "dark device on the counter." Patients are given a quiet vitals...

Read more

Ambience Healthcare Announces Nikhil Buduma as New Chief Executive Officer

September 22, 2025 6:00 PM

Ambience Healthcare, the leading ambient AI platform for documentation, coding, and clinical workflows, today announced that Co-Founder and Chief Scientist Nikhil Buduma will step into the role of Chief Executive Officer. Ambience Co-Founder Mike Ng, who served as CEO since the company's founding, will shift to the full-time executive role of President and Chairman."I am thrilled for Nikhil to step into the role of CEO," shared Mike Ng, Ambience...

Read more

NHI Prices Offering of Senior Notes

September 22, 2025 5:00 PM

National Health Investors, Inc. (NYSE:NHI) announced today that it priced an offering of $350 million aggregate principal amount of 5.350% Senior Notes due 2033 (the "Notes"). The Notes will be issued at 98.903% of par value with a coupon of 5.350%. Interest on the Notes is payable semi-annually on February 1 and August 1 of each year, commencing February 1, 2026. The Notes will mature on February 1, 2033. The offering is expected to close on...

Read more

Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board

September 22, 2025 5:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce the appointment of Dr. Michael Lock, Professor in the Department of Oncology and the Department of Medical Biophysics at the University of Western Ontario, to its Scientific and Clinical Advisory Board. Dr. Lock's expertise in clinical trial design, translational oncology, and multidisciplinary cancer care will...

Read more

Owen Mumford Introduces Empelvic(R) Cushion to the U.S Market

September 22, 2025 4:00 PM

Owen Mumford, a global leader in innovative medical devices, today announced the U.S. launch of Empelvic, a specially designed cushion that supports effective pelvic floor training. Pelvicon 2025, the premier conference for pelvic floor physical therapists, will serve as the kick-off event for the U.S. launch of Empelvic, taking place in Atlanta, Georgia, from September 25-27, 2025.Pelvic floor health is a vital part of overall wellness, yet it...

Read more

Black Book Research Releases 2025 Middleware Mandate Report: First Global Vendor Benchmarking Tied to TEFCA and EHDS Compliance

September 22, 2025 4:00 PM

Black Book Research today announced the release of its 2025 Middleware Mandate Report, a comprehensive 90-page study capturing the pivotal role of middleware in healthcare's evolving data economy. For the first time, healthcare stakeholders have access to a comparative benchmarking of interoperability vendors across the U.S., Europe, Canada, APAC, and the Middle East, evaluating readiness under TEFCA (Trusted Exchange Framework and Common...

Read more

From Design to Impact: MilliporeSigma's First Climate-Neutral Manufacturing Facility

September 22, 2025 11:00 AM

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announces the opening of the company's first manufacturing facility designed for climate-neutral operations in Blarney Business Park, Cork, Ireland. This milestone marks a significant step towards the company's commitment to achieving a 50% reduction in Scope 1 & 2 emissions and 52% per Euro value added in Scope...

Read more

iTolerance, Inc. Appoints Sandra Cohen Kalter to Strategic Advisory Group

September 22, 2025 10:00 AM

iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced the appointment of Sandra Cohen Kalter to its Strategic Advisory Group."This appointment represents another step toward bolstering our ability to navigate complex regulatory pathways, potentially accelerate clinical translation and unlock the full potential of our...

Read more

MentalHealth.com Acquires Therapy.ai to Advance Person-Centered Systems of Care

September 22, 2025 9:00 AM

MentalHealth.com today announced its acquisition of Therapy.ai, a move that advances artificial intelligence in mental health care. This milestone positions MentalHealth.com to deliver safe, compliant AI solutions at the intersection of technology and therapy.A Safe Approach to AI in Mental HealthNearly 23% of Americans face bans or proposed restrictions on AI therapy at a time when mental health needs are rising sharply worldwide1. Concerns...

Read more